Clovis oncology
Showing 1 - 25 of 2,088
Prostate Cancer Trial in Salt Lake City (Rucaparib)
Active, not recruiting
- Prostate Cancer
-
Salt Lake City, UtahHuntsman Cancer Institute
Jun 23, 2022
Solid Tumors, Adult, Metastatic Cancer Trial in San Francisco (Gallium-68 labelled (68Ga-) FAP-2286, Positron Emission
Recruiting
- Solid Tumors, Adult
- Metastatic Cancer
- Gallium-68 labelled (68Ga-) FAP-2286
- +2 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Aug 1, 2022
Metastatic Castration-resistant Prostate Cancer Trial in San Francisco, Providence (Rucaparib, Copanlisib)
Active, not recruiting
- Metastatic Castration-resistant Prostate Cancer
-
San Francisco, California
- +1 more
Nov 22, 2022
Liver Fibrosis, Pulmonary Fibrosis, Myocardial Fibrosis Trial in San Francisco (68Ga-FAP-2286, Positron Emission Tomography
Recruiting
- Liver Fibrosis
- +2 more
- 68Ga-FAP-2286
- Positron Emission Tomography (PET)
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jan 5, 2022
Mesothelioma, Malignant Trial in Leicester (Rucaparib, Abemaciclib, pembrolizumab & bemcentinib)
Recruiting
- Mesothelioma, Malignant
- Rucaparib
- +4 more
-
Leicester, United KingdomUniversity Hospitals of Leicester NHS Trust
Apr 6, 2022
Breast Cancer Trial in United States (Rucaparib, Radiotherapy)
Active, not recruiting
- Breast Cancer
- Rucaparib
- Radiotherapy
-
Norwalk, Connecticut
- +7 more
Aug 31, 2022
Small Cell Lung Cancer Trial in Lexington (Rucaparib and Nivolumab)
Recruiting
- Small Cell Lung Cancer
- Rucaparib and Nivolumab
-
Lexington, KentuckyMarkey Cancer Center, University of Kentucky
Aug 9, 2021
Endometrial Cancer, Uterine Carcinosarcoma Trial in New York, Bethlehem, Milwaukee (Rucaparib, Bevacizumab, Atezolizumab)
Active, not recruiting
- Endometrial Cancer
- Uterine Carcinosarcoma
- Rucaparib
- +2 more
-
New York, New York
- +2 more
Apr 4, 2022
BRCA1 Gene Mutation, BRCA2 Gene Mutation, Folate Receptor Alpha Positive Trial in Columbus (other, biological, drug)
Active, not recruiting
- BRCA1 Gene Mutation
- +9 more
- Laboratory Biomarker Analysis
- +3 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Sep 16, 2022
Stage IV NSCLC Trial in Ann Arbor, Saint Louis, Columbus (Pembrolizumab, Pemetrexed, Carboplatin)
Recruiting
- Stage IV Non-small Cell Lung Cancer
- Pembrolizumab
- +3 more
-
Ann Arbor, Michigan
- +2 more
Oct 4, 2021
Solid Tumor, Unspecified, Adult Trial in San Francisco (Rucaparib, Irinotecan)
Completed
- Solid Tumor, Unspecified, Adult
-
San Francisco, CaliforniaUniversity of California San Francisco
Mar 2, 2021
Esophagus Cancer, Adenocarcinoma, Stomach Cancer, Adenocarcinoma Trial in United States (Rucaparib, Ramucirumab, Nivolumab)
Recruiting
- Esophagus Cancer, Adenocarcinoma
- Stomach Cancer, Adenocarcinoma
- Rucaparib
- +2 more
-
Chicago, Illinois
- +7 more
Jan 31, 2022
Prostate Cancer, Endometrial Cancer Trial in Chicago (Rucaparib, Nivolumab)
Terminated
- Prostate Cancer
- Endometrial Cancer
-
Chicago, IllinoisUniversity of Chicago Medical Center
Feb 15, 2021
Rucaparib in Rucaparib Access Program in Spain - A GEICO Study
Completed
- Epithelial Ovarian Cancer
- +2 more
-
Almería, Andalucía, Spain
- +22 more
Sep 22, 2022
Advanced Gastric Cancer Trial in Worldwide (Nivolumab, Ipilimumab, Relatlimab)
Active, not recruiting
- Advanced Gastric Cancer
- Nivolumab
- +4 more
-
Phoenix, Arizona
- +34 more
Aug 18, 2022
Carcinoma, NSCLC Trial in Worldwide (nivolumab, ipilimumab, cabozantinib)
Withdrawn
- Carcinoma, Non-small Cell Lung Cancer
- nivolumab
- +5 more
-
Detroit, Michigan
- +22 more
Mar 8, 2022
Cancer, Tumors, Tumor Trial in Netherlands (Panitumumab, Olaparib, Dabrafenib)
Recruiting
- Cancer
- +3 more
- Panitumumab
- +32 more
-
Amersfoort, Utrecht, Netherlands
- +34 more
Oct 26, 2021
Metastatic Castration-Resistant Prostate Cancer, Ovarian Cancer, Epithelial Ovarian Cancer Trial in Worldwide (Rucaparib)
Enrolling by invitation
- Metastatic Castration-Resistant Prostate Cancer
- +5 more
-
Lakewood, Colorado
- +37 more
Jan 18, 2022
Adenocarcinoma of the Oesophagus, Adenocarcinoma of the Gastro-oesophageal Junction, Adenocarcinoma of the Stomach Trial in
Recruiting
- Adenocarcinoma of the Oesophagus
- +2 more
- Capecitabine
- +4 more
-
Sutton, United KingdomThe Royal Marsden NHS Foundation Trust, Downs Road, Sutton
Feb 19, 2020